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The heterogeneous nuclear ribonucleoprotein K (hnRNP K), is a ubiquitously expressed protein that interacts with signal transducers,
proteins that modulate gene expression and selective RNA and DNA motifs. K protein is modified in response to extracellular signals
and directly regulates rates of transcription and translation. We used serum-treated hepatocyte culture, liver after partial
hepatectomy and hepatic neoplasms as systems to compare expression, subcellular distribution and tyrosine phosphorylation of K
protein in quiescent and dividing cells. The results show that expression of K protein mRNA was increased in states of enhanced
proliferation. Levels of nuclear K protein were also higher in proliferating compared to resting cells. In contrast, levels of cytoplasmic K
protein were the same or lower in dividing compared to quiescent cells. States of enhanced proliferation were also associated with
increased levels of K protein tyrosine phosphorylation. Nuclear shift of K protein in dividing cells may reflect involvement of K protein
in signalling multiple events that regulate expression of genes in proliferating cells.
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The heterogeneous nuclear ribonucleoprotein K (hnRNP K)
protein is an abundant and ubiquitous factor that interacts with
a diverse types of molecules (Bomsztyk et al, 1997) including RNA
(Dejgaard et al, 1994), DNA (Ostrowski et al, 1994), factors
involved in chromatin remodelling (Denisenko and Bomsztyk,
1997; Shnyreva et al, 2000), transcription (Du et al, 1993), RNA
splicing (Shnyreva et al, 2000) and translation (Bomsztyk et al,
1997). K protein also interacts with factors involved in signal
transduction, including inducible kinases (Weng et al, 1994;
Bustelo et al, 1995; Van Seuningen et al, 1995). The diversity of its
interactions can be accounted for by K protein’s modular structure
(Bomsztyk et al, 1997). K protein is modified in response to
changes in extracellular environment including cytokines, growth
factors and oxidative stress (Ostrowski et al, 1991; 2000a). Changes
in K protein phosphorylation regulate its interaction with nucleic
acids and protein partners (Schullery et al, 1999; Ostrowski et al,
2000a; Ostareck-Lederer et al, 2002). These properties suggest that
K protein bridges signal transduction pathways to nucleic acid-
directed processes. In further support of this model, several studies
have shown that K protein can alter rates of transcription
(Michelotti et al, 1996) and translation (Ostareck et al, 1997).
K protein contains three K homology (KH) domains (Siomi et al,
1993) that are highly conserved in organisms as diverse as yeast
and mammals. In Drosophila, the KH domain-containing product,
bancal, is most closely related to the mammalian K protein. Null
and weak alleles of bancal impair adult appendages morphogenesis
(Charroux et al, 1999; Gates and Thummel, 2000). This phenotype
reflects decreased cell proliferation in the imaginal disc cells
(Charroux et al, 1999). Expression of human K protein rescues
these fly phenotypes, suggesting that like the structure, K protein
function has also been evolutionarily conserved.
Since bancal has been shown to affect cell proliferation in
Drosophila (Charroux et al, 1999; Gates and Thummel, 2000), we
wondered if K protein expression is altered in proliferating
mammalian cells. To explore the role of K protein in mitogenic
responses, we chose hepatic cell lineage because cell cultures and
useful models of enhanced proliferative states in intact organs and
cancer are available. Our study showed increased expression of K
protein mRNA and a nuclear shift of K protein in cultured serum-
treated hepatocytes, in regenerating livers postpartial hepatectomy
and in hepatic neoplasms.
MATERIAL AND METHODS
Cells
Rat hepatoma cells expressing human insulin receptors, HTC-IR,
were grown in plastic cell culture flasks in DME media
supplemented with 10% FBS, 2mM glutamine, penicillin
(100Uml
 1), streptomycin (0. 01%), and humidified with 7/93%
CO2/air gas mixture.
Animals
Mice were housed under constant room temperature with a 12:12-
h light–dark and permitted free access to water and to standard
food pellets. The animals received humane care in compliance with
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spontaneous hepatocellular neoplasms, and BALB/c mice with liver
implanted L1 sarcoma tumors (Ostrowski et al, 2000c). L1 sarcoma
cell line was propagated under standard conditions in MEM
supplemented with 10% FCS and antibiotics. BALB/c mice, 2
months old, were anaesthetised with ether for laparotomy, and 10
5
viable L1 cells suspended in 0.05ml of PBS were injected under the
capsule of left lateral lobe of the liver. After 3 weeks, animals with
implanted hepatic tumours were used in these studies. Mice
anaesthetised by ether were killed, the livers were rapidly resected
and classified by gross examination into tumour and hepatic
tissue. Two portions of each specimen were frozen in liquid
nitrogen and stored in  801C until use. The remaining portions
were fixed in formalin and embedded in paraffin for histological
examination.
Partial hepatectomy was performed under ether anaesthesia on
2-month-old BALB/c male mice. Under aseptic conditions animals
were subjected to mid-ventral laparatomy and resection of the left
lateral lobe which constitutes about one-third of the total liver. The
removed lobe was immediately frozen in liquid nitrogen and
stored at  801C until use. After the indicated times, animals were
killed and the remnant liver was rapidly collected and frozen.
Sham-operated animals underwent mid-ventral laparatomy with-
out resection of liver lobe.
Northern blot analysis and RT–PCR
Total RNA was prepared from tissues and cell pellets using TRIzol
reagent. A measure of 10mg of total RNA was denatured with
formaldehyde–formamide and electrophoresed in a 1% agarose/
formaldehyde gel. RNA was then transferred to Hybond N nylon
membranes in 10 SSC. The membranes were incubated at 651C
for 20h with 2 10
7d.p.m. of the
32P-labelled DNA probes in the
hybridisation buffer (6 SSC, 0.5% Ficoll, 0.5% PVP, 0.5% BSA,
0.5% SDS, 100mgml
 1 herring sperm DNA). Excess probe was
removed from the membrane by serial washes at 651Ci n1 SSC/
0.1% SDS. The hybridised probes were visualised by autoradio-
graphy.
A measure of 5mg of total RNA was reverse transcribed using
Superscript II RT (GIBCO-BRL) and oligo-dT in 20ml volume as
per the manufacturer’s protocol. RT reactions were diluted 1:10
with water, and PCR was carried out as described previously
(Ostrowski et al, 2003b) using 2ml of cDNAs and primers for c-
myc.[ a-
32P]dCTP (NEN) was used to label the PCR products. PCR
products were resolved on native 5% polyacrylamide gels, then the
gels were dried and the PCR products were quantified using a
phosphorimager. Densitometric analysis was performed using
OptiQuant
TM Image Analysis Software (Packard). The levels of
band intensities after background subtraction were expressed in
digital light units (DLU).
Cell extracts
Cytoplasmic and nuclear extracts were prepared as described
previously (Ostrowski et al, 1991, 2000b). Separation of the nuclear
fraction from the cytosol was monitored with the cytosolic enzyme
marker lactic dehydrogenase and the purity of nuclear extracts was
greater than 92%. The protein concentration was measured using
MicroBCA protein assay, Pierce Biotechnology (Rockford, IL,
USA).
Electrophoresis and immunoblotting
Equal amounts of sample protein (50mg) were separated by 10%
SDS–PAGE and immunostained by standard methods as described
previously (Ostrowski et al, 1991, 2000b).
Cell proliferation
DNA synthesis was determined by the incorporation of
3H-
thymidine. Exponentially growing HTC-IR cells were harvested,
seeded at a density of 5 10
3 per well in 96-well plates and then
grown in DMEM containing 10% FBS. After 24h, cells were made
quiescent by 48h serum deprivation and then they were treated
with 15% FBS. Cell growth was monitored at 3, 6 and 24 by adding
0.5mCi of
3H-thymidine to each well for 3h. Finally, cells were
harvested, DNA was collected on GFC filters, and the radioactivity
was determined by scintillation counting. Three independent
experiments were performed and all assays were repeated in
octuplicate.
Mice with spontaneous hepatocellular neoplasms and those after
sham or partial hepatectomy were given 25mCi of
3H-thymidine
intraperitoneally 1h prior to euthanasia. Hepatic DNA was
extracted by proteinase K digestion followed by phenol–chloro-
form extraction, and the quantity of the DNA was measured
spectrometrically. The radioactivity of 100-mg samples of total
hepatic DNA was determined by scintillation counting.
Quantification
Quantification analysis was performed either by photographing
with a digital camera (DC40, Kodak) or scanning the intensity of
the bands with an ImageScanner, Amersham Pharmacia Biotech or
by scanning
32P radioactivity with a Phosphorimager apparatus.
Densitometric analysis was performed using OptiQuant
TM Image
Analysis Software (Packard).
Statistical analysis
Results are presented as meansþs.d. Significant difference
between mean values was assessed by means of analysis of
variance (ANOVA). P-values for differences from control results
were calculated using the Bonferroni method. Means were
considered to be different if Po0.05.
RESULTS
Expression and subcellular localisation of K protein from
serum-treated hepatocyte culture
The HTC-IR cells have been a useful system to study signal
transduction and gene expression in hepatocyte line grown in
culture (Iwamoto et al, 1981; Ostrowski et al, 2001). We used
3H-
thymidine uptake to test their proliferative response to serum
treatment. Quiescent HTC-IR cells preincubated with
3H-thymi-
dine were treated with 15% serum. At given time points, cells were
harvested and
3H counts were measured by scintillation counter.
Results shown in Figure 1 illustrate that increased
3H-thymidine
uptake into DNA was not seen at 6h, but there was a strong
increase in uptake 24h after serum treatment. This
3H-thymidine
uptake kinetics is similar to studies in other hepatoma cell lines
(Kadowaki and Kitagawa, 1988). These results show that the HTC-
IR cells are a suitable system to study mitogenic responses to
serum treatment.
To test if induction of cell cultures to divide alters K protein
expression, serum-deprived hepatoma HTC-IR cells were treated
with 15% FCS. At given time points, cells were harvested and RNA
and protein extracts were prepared (Figure 2). Northern blot
analysis revealed two constitutively expressed K protein tran-
scripts, 2.2 and 3.0kb. The level of expression of the longer
transcript was lower. Serum treatment of resting HTC-IR cells
increased the level of both transcripts. The increase was first seen
after 1h of stimulation, peaked at 6h and decreased after 24h of
serum treatment (Figure 2A). At peak levels (6h), there was a six-
fold increase in both the short and long transcript in response to
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proliferation is associated with increased K protein gene expres-
sion.
Total cytoplasmic and nuclear extracts (50mg each) were
analysed by SDS–PAGE and anti-K protein immunoblotting.
Western blot analysis revealed that serum treatment induced a
sustained increase in K protein levels in both cytoplasmic and
nuclear fractions (Figure 2B). The increase was far more
pronounced in the nuclear fractions where 24h following
treatment there was a 3.6-fold increase in K protein levels
compared to resting cells. At the same time point, K protein level
in cytoplasmic extracts increased by 40%. These results suggest
that the serum-induced increase in K protein mRNA levels
(Figure 2A) results in increased K protein synthesis and that most
of the newly synthesised K protein is directed to the nucleus.
K protein is tyrosine phosphorylated by Src-family of kinases
(Ostrowski et al, 2000a; Ostareck-Lederer et al, 2002). Serum
treatment increases tyrosine phosphorylation of many proteins
involved in signal transduction and gene expression (Wang, 1994).
To test if K protein is tyrosine phosphorylated in response to a
mitogenic signal, K protein was immunoprecipitated with anti-K
protein from whole-cell lysates of quiescent and serum-treated
HTC-IR cells and the immunoprecipitates were analysed by anti-
phosphotyrosine and anti-K protein immunoblots (Figure 2C).
There was constitutive tyrosine phosphorylation of K protein in
quiescent cells, and following serum treatment the level of tyrosine
phosphorylation of K protein increased transiently. Serum
treatment increased the total amount of immunoprecipitated K
protein, but unlike tyrosine phosphorylation this increase was
sustained. The increased level of immunoprecipitated K protein
from total cell lysates largely reflects the increase in nuclear K
protein (Figure 2B).
Expression and subcellular distribution of K protein in
injured livers
Partial hepatectomy leads to hepatic regeneration resulting in
almost complete restoration of the liver mass (Taub, 1996). The
mechanisms initiating and controlling hepatocyte ‘priming’
involve activation of several nonspecific factors in the initiating
phase. These cellular events include increased Na
þ flux into the
cells, elevation in cAMP content, activation of ornithine decarbox-
ylase and Na
þ/K
þ-ATPase, expression of and response to growth
factors and cytokines, activation of transcription factors (NF-kB,
Stat-3, AP-1, C/EBP-b) and induction of immediate-early genes
(e.g. c-fos,c - jun,c - myc) (Taub, 1996; Rozga, 2002; Zimmermann,
2002).
3H-thymidine uptake into the DNA was used to assess
hepatocyte proliferation following partial hepatectomy. Mice were
anaesthetised, and after laparatomy in one group of animals the
livers were left alone (sham operated), while in the other group the
left lobe of the liver was removed (30% hepatectomy)–partial
hepatectomy group. Abdominal cavities were closed and the
animals were allowed to recover from the ether anaesthesia. At
1h prior to harvesting the livers, mice were injected with
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Figure 1
3H-thymidine uptake in serum-treated hepatocytes. Cells were
grown in 96-well plates in DMEM containing 10% FBS. After 24h, cells
were made quiescent by 48h serum deprivation and then cells were either
untreated (0 time point) or were treated with 15% FBS for 6 or 24h. Cell
proliferation was monitored by adding 0.5mCi of
3H-thymidine to each well
for another 3h. The radioactivity of collected cellular DNA was determined
by scintillation counting. Three independent experiments were performed
and the results represent means7s.d. of radioactivity counts expressed in
c.p.m.
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Figure 2 K protein expression in serum-treated hepatocytes. After 48h
of serum deprivation, HTC-IR cells were treated with 15% FCS. At given
time points, cells were harvested, and total RNA and proteins as well as
nuclear and cytoplasmic proteins were extracted. (A) Total RNA was
electrophoresed in a 1% agarose/formaldehyde gel and RNA was visualised
with ethidium bromide and photographed with digital camera (DC40,
Kodak). After RNA transfer, the nylon membranes were probed with
32P-
labelled K protein cDNA. Autoradiographs were photographed with a
digital camera (DC40, Kodak). Densitometric analysis was carried out using
OptiQuant
TM Image Analysis Software (Packard meriden, CT, USA). The
mRNA levels shown in the graph were normalised to the levels of 28S. (B)
Protein extracts were resolved by SDS–PAGE followed by Western
blotting with anti-K protein antibody. Blots were scanned, and densito-
metric analysis of K protein bands was performed using OptiQuant
TM
Image Analysis Software. (C) Anti-K protein immunoprecipitates from total
cell extracts (300mg protein) were resolved by SDS–PAGE and
immnunobloting was performed with either anti-phosphotyrosine (pTyr)
or anti-K protein (K) antibodies. Densitometric analysis was done as in (B).
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livers were removed. As shown in Figure 3A, at 6h following
surgery, no differences in
3H-thymidine uptake into the livers were
seen between sham and partial hepatectomy animals. In contrast,
hepatic DNA synthesis was induced 24h after partial hepatectomy,
but no increase was seen in the control sham-operated mice.
Expression of proliferating cell nuclear antigen (PCNA) correlates
well with hepatocyte proliferation (Wolf and Michalopoulos, 1992).
Proliferating cell nuclear antigen protein levels were determined in
liver lysates at 6 and 24h following surgery by immunoblot
analysis. A representative blot is presented as an inset in Figure 3A.
Not unexpectedly, the increase in the partial hepatectomy-induced
DNA synthesis was mirrored by the increased PCNA expression.
Liver lysates contain proteins from hepatocytes and other cell
types. Thus, next we did PCNA immunocytochemistry of the livers
from either sham-operated animals or animals following partial
hepatectomy that allows direct visualisation of hepatocytes. In
sham-operated mice there was little or no PCNA detected. In
contrast, there was very strong nuclear PCNA staining of
hepatocytes 24h following partial hepatectomy (Figure 3B). These
observations are consistent with previous partial hepatectomy
studies carried out in rats and mice where DNA synthesis occurred
in a single peak 18–24h after resection (Lambotte et al, 1997;
Freeman et al, 1999).
As partial hepatectomy is an excellent model of cellular
proliferation in an intact organ, we used it to correlate changes
in cell proliferation with K protein expression and subcellular
distribution in this system (Figure 4). Mice were anaesthetised, and
after laparatomy the left lobe of the liver was removed (30%
hepatectomy) and rapidly frozen. Abdominal cavities were closed
and the animals were allowed to recover from the ether
anaesthesia. At given time points, mice were again ether
anaesthetised and the remnant livers were harvested and rapidly
frozen. Total RNA, total cell lysates, cytoplasmic and nuclear
extracts were prepared from the resected lobes and from the
remnant livers. All analyses presented were carried out by
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Figure 3 Cell proliferation indices in liver after partial hepatectomy of
anaesthetised mice. (A) Mice after sham or partial hepatectomy (PH)
(three animals in each group at 6 and 24h after surgery) were given 25mCi
of
3H-thymidine intraperitoneally 1h prior to euthanasia. The livers were
harvested, hepatic DNA was extracted and the radioactivity of 100-mg
samples of total hepatic DNA was determined by scintillation counting.
Total DNA was measured using a spectrophotometer. The results
represent means7s.d. of radioactivity counts expressed in c.p.m.mg
 1
DNA. The insets represent Western blot analysis of PCNA in liver lysates.
(B) Immunocytochemistry of the liver tissues was performed as previously
described (Kupryjanczyk et al, 2003). Briefly, portions of the liver tissues
from sham-operated mice and animals following PH (24h) were
embedded in paraffin. After heat-induced epitope retrieval, sections were
incubated with anti-PCNA antibody (1:4000, Santa Cruz) for 1h at room
temperature. Biotinylated goat anti-mouse IgG was used as a detection
system.
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Figure 4 K protein expression after partial hepatectomy in mice. (A)
Total RNA was extracted from resected lobes (before) and from the
remnant livers (after). Northern blots were probed with
32P-labelled K
protein cDNA. The slower (long) and the faster (short) K protein mRNA
transcripts (upper gel) were analysed by densinometry. The intensity of the
K protein mRNA bands was normalised to the levels of 28S RNA (lower
gel). The results in the graph are expressed as a ratio of levels after (after)
to before (before) partial hepatectomy. (B and C) Protein extracts
prepared from livers before and after partial hepatectomy were analysed
by anti-K protein Western blots as in Figure 1. Results are expressed as a
ratio of levels measured after (after) and before (before) partial
hepatectomy of the same liver. (B) Levels of K protein in cytoplasmic
(CE) and nuclear (NE) extracts. (C) Anti-K protein immunoprecipitates
from whole-cell lysates analysed with anti-phosphotyrosine (pTyr) and anti-
K protein (K) antibody.
K protein levels in cell proliferation
J Ostrowski and K Bomsztyk
1496
British Journal of Cancer (2003) 89(8), 1493–1501 & 2003 Cancer Research UK
M
o
l
e
c
u
l
a
r
a
n
d
C
e
l
l
u
l
a
r
P
a
t
h
o
l
o
g
ycomparing levels in the remnant liver to the levels measured in the
resected lobe of the same animal (Figure 4).
As in case of HTC-IR cells (Figure 2A), Northern blot analysis
showed that in an intact liver there is constitutive expression of the
two transcripts of K protein (Figure 4A). The level of both
transcripts increased after resection, a change first seen in the
remnant liver 3h after resection; the peak effect occurred at 6h
and the mRNA levels came down to baseline 24h postpartial
hepatectomy. These results show transient increase in K protein
mRNA levels that is associated with cell proliferation in vivo.
Western blot analysis revealed that there was a transient
increase in nuclear K protein, with peak levels (three-fold increase)
seen 3h postpartial hepatectomy (Figure 4B). Concurrently, there
was a decrease in cytoplasmic K protein levels. At 24h postpartial
hepatectomy, the levels of K protein in the cytoplasmic and nuclear
extracts from remnant livers returned to baseline. These results
revealed that following partial hepatectomy, there is nuclear
translocation of K protein from the cytoplasm.
Liver injury activates tyrosine kinases leading to phosphoryla-
tion of such key factors as the cyclins (Diehl and Rai, 1996;
Spiewak Rinaudo and Thorgeirsson, 1997). We used immunopre-
cipitation assays to assess whether partial hepatectomy alters the
level of tyrosine phosphorylation of K protein (Figure 4C). Anti-
phosphotyrosine blots of K protein immunoprecipitations showed
that in the intact liver there is constitutive tyrosine phosphoryla-
tion of K protein. Liver resection induced a transient increase in
the level of K protein tyrosine phosphorylation, with the peak
effect (3.5-fold increase) observed in the remnant liver 1h after
resection (Figure 4C, pTyr). Since K protein transcripts were
transiently induced postpartial hepatectomy (Figure 4A), it was
surprising to see that the level of K protein immunoprecipitated
from total cell lysates from remnant livers did not change
appreciably (Figure 4C, IP-K).
Expression and subcellular distribution of K protein in
hepatic neoplasms
CBA-T6/W mice develop spontaneous liver tumours including
hepatocellular adenoma and carcinoma (Ostrowski et al, 2000c).
To assess the rates of proliferation of these tumours, we again used
3H-thymidine incorporation (Figure 5). At 1h after injecting
3H-
thymidine, mice were ether anaesthetised, the livers were resected
and carcinomas were dissected out from the normal liver
parenchyma. DNA was purified from normal and cancer tissue
and
3H counts were assessed as before. A part of the resected tissue
was used for histology. Although
3H-thymidine incorporation
tended to be higher in hepatocellular carcinomas than in the
surrounding histologically normal hepatic tissue, these differences
were not statistically significant. This is not surprising since these
tumours are slow growing (Szymanska, 1991).
We used the mice with hepatocellular carcinoma to assess K
protein expression and its subcellular distribution. The Livers
harbouring tumours were resected from anaesthetised mice and
carcinomas were dissected out from the normal liver parenchyma.
As before, a part of the resected tissue was used for histology and
the rest was rapidly frozen. Figure 6 shows finding in three animals
with hepatocellular carcinoma. Northern blot analysis revealed two
transcripts, and in all three animals the levels of K protein mRNA
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Figure 5
3H-thymidine uptake in mouse spontaneous hepatic adeno-
carcinoma hepatocellular carcinomas. Mice harbouring spontaneous
hepatocellular carcinomas (five animals) were given 25mCi of
3H-thymidine
intraperitoneally 1h prior to euthanasia. The livers were harvested and
hepatic DNA was extracted from the liver tumours and from the normal
surrounding tissues. Radioactivity of 100-mg samples of total hepatic DNA
was determined by scintillation counting. The results represent means7s.d.
(n¼5) of radioactivity counts expressed in c.p.mmg
 1 DNA.
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Figure 6 K protein expression in spontaneous hepatic adenocarcinoma
in mice. (A) Total RNA was extracted from hepatic adenocarcinoma and
the livers harbouring these tumours. Northern blots were probed with
32P-
labelled K protein cDNA. The slower (long) and the faster (short) K protein
mRNA transcripts (upper gel) were analysed by densinometry. The
intensity of the K protein mRNA bands was normalised to the levels of 28S
RNA (lower gel). The results in the graph are expressed as a ratio of levels
measured in the adenocarcinoma (tumour) and those measured in the liver
(normal) harbouring the tumour. (B and C) Protein extracts prepared
from liver adenocarcinomas (tumour) and normal liver tissue (normal)
surrounding these tumours were analysed by anti-K protein Western blots
as in Figure 1. Results are expressed as the ratio of levels measured in the
tumour (tumour) and those in the normal parenchyma (normal) of the
same liver. (B) Levels of K protein in cytoplasmic (CE) and nuclear (NE)
extracts. (C) Anti-K protein immunoprecipitates from whole-tissue extracts
analysed with anti-phosphotyrosine (pTyr) and anti-K protein (K) antibody.
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parenchyma (Figure 6A). The increased K protein mRNA levels in
cancer is consistent with the findings in serum-treated HTC-IR
(Figure 2A) and in livers postpartial hepatectomy (Figure 4A).
In further agreement with the other results (Figures 2 and 4),
Western blots showed that in all the three animals the level of K
protein in nuclear extracts was higher in the tumour than in the
normal liver harbouring these cancers (an average 66% higher in
the tumour) (Figure 4B). In contrast, the levels of K protein in
cytoplasmic extracts from cancer were not different from the
normal parenchyma. In all the three animals, the level of tyrosine
phosphorylation of K protein in the tumours was higher than in
the normal liver (average 20% difference), but in part this might be
explained by the slightly higher levels of K protein immunopre-
cipitated from the cancer (Figure 6C).
We also assessed K protein expression and subcellular distribu-
tion in hepatic adenoma (seven animals) and in L1 sarcoma
implanted into liver (six animals) (Figure 7). The level of K protein
in the cytoplasmic extracts from liver adenomas was the same as in
the adjacent normal parenchyma (Figure 7A, CE). In six out of
seven animals, the level of nuclear K protein was higher in the
hepatic adenomas compared to the normal liver parenchyma
surrounding the tumours (Figure 7A, NE). On an average, the level
of K protein in the adenomas was 38% higher than in normal
tissues. In the implanted sarcomas, which are more aggressive
tumours, in all the six animals the level of nuclear K protein was
higher than in the nuclear extracts from livers harbouring these
tumours (Figure 7B). On an average, K protein levels in the nuclear
extracts from sarcomas was 2.5-fold higher than those measured in
nuclear extracts from normal liver parenchyma adjacent to these
tumours. As in the hepatocellular neoplasms (Figures 6 and 7A),
the levels of K protein in cytoplasmic extracts from sarcomas and
normal liver tissues were not different (Figure 7B).
Activation of c-myc gene expression in serum-treated
HTC-IR cells, in injured livers and liver tumours
Mitogenic stimulation leads to rapid induction of immediate-early
genes (Herschman, 1991). Immediate-early genes are activated in a
protein synthesis-independent manner and are involved in cell
proliferation (Jochum et al, 2001). They regulate later phases in G1
of the cell cycle and represent diverse classes of genes including
those encoding transcription factors, c-myc is one of the
immediate-early genes, whose expression is transiently increased
in G1.c - myc encodes a transcription factor that targets a host of
genes that regulate cell proliferation (Bouchard et al, 1998). With
regard to the liver, antisense oligomer to c-myc can reduce cell
proliferation in the regenerating rat liver, suggesting that
expression of this gene plays a role in the process of regeneration
(Arora et al, 2000). In response to serum treatment, K protein is
recruited to multiple sites along the c-myc locus (Ostrowski et al,
2003a). In gene reporter systems, K protein was shown to regulate
c-myc promoter (Michelotti et al, 1995, 1996) and translational
elements activity (Evans et al, 2003). Studies in breast carcinoma
lines suggested that increased expression of K protein enhanced c-
Myc levels (Mandal et al, 2001). Taken together, these studies
suggest that K protein regulates c-myc gene expression on both
transcriptional and post-transcriptional levels.
We next compared semiquantitative RT–PCR analysis of RNA
in serum-treated HTC-IR cells, in resected livers and in hepatic
tumours to correlate c-myc transcript levels with K protein
expression in these models (Figure 8). Treatment of serum-starved
HTC-IR cells rapidly induced the c-myc expression (Figure 8A),
with a peak in c-myc expression seen at 1h after serum treatment.
This time course is similar to the kinetics of serum-induced
transient recruitment of K protein to the promoter and transcribed
region of the c-myc locus in these cells (Ostrowski et al, 2003a).
The kinetics of c-myc mRNA expression after partial hepatectomy
(Figure 8B) was similar to that seen in cultured serum-treated
hepatocytes in vitro; a large peak in c-myc transcript levels was
seen at 1h following partial resection, and its level declined nearly
to baseline at 6h. These c-myc results are similar to the studies
published by others (Taub et al, 1987). Similarly, there was also
increased c-myc transcript expression in hepatocellular carcinoma
compared to normal tissue, that is, an eight-fold higher levels
(Figure 8C).
DISCUSSION
Treatment of resting HTC-IR cells with serum resulted in sustained
increase in nuclear K protein with little changes in cytoplasmic K
protein (Figure 2B). Similar observations were made in hepatic
tumours (Figures 6B and 7). While the levels of K protein in
nuclear extracts were higher in the neoplasms compared to the
adjacent normal parenchyma, the levels of K protein in the
cytoplasmic fractions were the same in the neoplastic and the
normal surrounding tissues. Serum-treated HTC-IR cells and
tumours represent sustained states of enhanced cell proliferation.
In contrast, following partial hepatectomy, the number of cycles of
cell division is limited. Within minutes after partial hepatectomy,
quiescent liver cells in the remaining lobes enter a state of
replicative competence (an initiation phase), followed by a
proliferation phase and, finally, by a termination phase (Zimmer-
mann, 2002). Thus, it is not surprising that postpartial hepatect-
omy there was only a transient nuclear shift of K protein that
peaked at 3h following liver injury and by 6h it was near baseline.
The kinetics of the nuclear shift of K protein in response to serum
treatment and following liver injury provides some clues regarding
the consequences of this effect. In response to serum treatment, K
protein is recruited to multiple sites along the c-myc locus
including both the promoter and the transcribed regions
(Ostrowski et al, 2003a). K protein binds in vitro CT-rich DNA
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Figure 7 Expression of K protein in spontaneous adenomas and
implanted sarcomas in mouse livers. Cytoplasmic (CE) and nuclear (NE)
extracts were prepared from spontaneous liver adenomas (adenoma),
implanted sarcomas (sarcoma) and normal liver parenchyma (normal)
surrounding these tumours. Levels of K protein were analysed in Western
blots as in Figure 1. Results are expressed as the ratio of levels measured in
the tumour (tumour) and those in the normal tissue (normal) of the same
liver.
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myc promoter activity in several types of cells including breast
cancer (Michelotti et al, 1996; Mandal et al, 2001). Here, we have
shown that c-myc expression is activated in hepatocyte culture in
response to mitogens and following liver injury (Figure 8A and B).
Taken together, these results suggest that at an early time point
following liver injury K protein may play a role in the induction of
c-myc gene. Expression of c-fos and egr-1 is also activated in
remnant liver following partial hepatectomy (Taub, 1996).
Promoters of both c-fos and egr-1 genes contain putative CT-like
K protein-binding motifs, and in response to serum treatment of
hepatocyte culture K protein is recruited to both egr-1 (Ostrowski
et al, 2003a) and c-fos (unpublished observations) loci. It is,
therefore, plausible that the role of the K protein fraction that is
newly directed to the nucleus in remnant livers is to regulate
transcription of these immediate-early genes and other factors that
mediate the enhanced cell proliferation during an initiation
(prereplicative) phase. Here, the increase in the level of tyrosine
phosphorylation of K protein (Figure 4C) may play a role in its
nuclear translocation and/or its recruitment to inducible tran-
scribed gene loci such as the immediate-early genes (Ostrowski
et al, 2003a).
Increased K protein expression has previously been found in
breast cancer cells. In that study, the authors provide evidence that
the increased K protein levels contribute to the enhanced c-myc
gene expression in these tumours (Mandal et al, 2001). The current
study demonstrates for the first time that there is a nuclear shift of
K protein in hepatic neoplasm and other states of enhanced
proliferation. As discussed above, there is considerable evidence
that K protein regulates c-myc gene expression, so the increased
level of K protein in the nucleus seen in tumours (Figures 6 and 7)
may play a role in enhanced expression of this immediate-early
gene in malignancy. K protein binding appears to be genomewide,
where it exhibits both constitutive and inducible interactions with
chromatin (Ostrowski et al, 2003a). Some of these interactions may
reflect direct binding of K protein to DNA. However, K protein
binds many proteins, DNA and RNA (Bomsztyk et al, 1997). Some
of the K protein partners are recruited to transcribed loci by
interacting with DNA, transcriptionally active complexes or with
nascent RNA. One or more of these K protein interactions could be
responsible for the recruitment of K protein to chromatin by an
indirect mechanism. Thus, the nuclear shift of K protein in
tumours (Figures 6 and 7) may reflect its involvement in multiple
DNA- and/or RNA-directed processes that are altered in malig-
nancies. With respect to nuclear K shift in cancer, two nuclear
processes seem relevant to consider. First, cisplatin cross-linking
in human breast cancer cells revealed that K protein is one of the
nuclear matrix proteins (Samuel et al, 1998). The key role of
nuclear matrix is to organise the chromatin topology so that it can
serve as a conducive template for transcription and replication.
Although much remains to be learned, abnormal nuclear matrix is
one of the morphologic hallmarks of cancer (Leman and
Getzenberg, 2002). Thus, the nuclear shift of K may reflect, in
part, altered protein composition of nuclear matrix in cancer. If so,
the ability of cisplatin to cross-link K protein to DNA may be one
of the mechanisms by which this chemotherapeutic agent inhibits
processes that compose transcription and replication (Samuel et al,
1998). Second, K and other hnRNP proteins bind mammalian
telomeric sequences (Lacroix et al, 2000; Ford et al, 2002) and
Saccharomyces cerevisiae K protein-like genes regulate telomeric
processes (Denisenko and Bomsztyk, 2002). These observations
suggest that K protein may be involved in maintaining the integrity
of mammalian telomeres. Preservation of telomere length which, in
part, results from reactivation of telomerase is another hallmark of
continuous cells growth, especially of advanced malignancies
(Neumann and Reddel, 2002). The increased nuclear levels of K
protein may play a role in the altered telomeric processes seen in
cancer.
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Figure 8 c-myc mRNA transcript levels in serum-treated hepatocyte
cultures (A), postpartial hepatectomy (B) and in hepatic tumours (C). (A)
Serum-deprived HTC-IR cells were treated with 15% FBS for 0, 1, 3, 6 and
24h. After harvesting the cells, total RNA was isolated and used in RT. PCR
was carried out using [a
32P]dCTP (0.5mCi per reaction) and c-myc primers
(forward: GCAAATGCTCCAGCCCCAGGTC; reverse: AGTCC-
CAAAGCCCCAGCCAAGGTT). PCR products were resolved by native
PAGE and were quantified using a phosphorimager (Cyclone, Packard
meriden, CT, USA). Results are expressed as fold increase in the mRNA
level at each time point of serum treatment compared to the levels seen in
untreated cells. The values represent means7s.d. (n¼3). (B) Partial
hepatectomy and control sham operation were carried out as in Figure 3.
At given time points following surgery, the livers were harvested from each
group and total RNA was isolated (three animals for each time point), c-
myc mRNA levels were determined by RT–PCR as above. Results are
expressed as fold increase in mRNA levels compared to sham-operated
mice. (C) Comparison of c-myc mRNA levels in spontaneous hepatocel-
lular carcinoma and the normal surrounding liver tissue, c-myc mRNA
levels were determined by RT–PCR and the
32P signal of the labelled
products is expressed in DLU. The results represent means7s.d.
(n¼5 animals).
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enhanced cell proliferation, there are increased K protein levels in
the nucleus. Induction of cell proliferation results in the activation
of a large repertoire of genes (Iyer et al, 1999). K protein is an
abundant factor involved in transcription, mRNA processing and
other events that compose gene expression. It is likely that the
increased K protein levels seen in the nuclei of the proliferating
cells serve to support nuclear process that not only composes
inducible expression of a very large number genes but also
maintains conducive chromatin topology in growing cells.
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